Cargando…
Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline
Treatment of ocular tumors on dedicated scattering-based proton therapy systems is standard afforded due to sharp lateral and distal penumbras. However, most newer proton therapy centers provide pencil beam scanning treatments. In this paper, we present a pencil beam scanning (PBS)-based ocular trea...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931109/ https://www.ncbi.nlm.nih.gov/pubmed/35301371 http://dx.doi.org/10.1038/s41598-022-08440-5 |
_version_ | 1784671186021515264 |
---|---|
author | Regmi, Rajesh Maes, Dominic Nevitt, Alexander Toltz, Allison Leuro, Erick Chen, Jonathan Halasz, Lia Rengan, Ramesh Bloch, Charles Saini, Jatinder |
author_facet | Regmi, Rajesh Maes, Dominic Nevitt, Alexander Toltz, Allison Leuro, Erick Chen, Jonathan Halasz, Lia Rengan, Ramesh Bloch, Charles Saini, Jatinder |
author_sort | Regmi, Rajesh |
collection | PubMed |
description | Treatment of ocular tumors on dedicated scattering-based proton therapy systems is standard afforded due to sharp lateral and distal penumbras. However, most newer proton therapy centers provide pencil beam scanning treatments. In this paper, we present a pencil beam scanning (PBS)-based ocular treatment solution. The design, commissioning, and validation of an applicator mount for a conventional PBS snout to allow for ocular treatments are given. In contrast to scattering techniques, PBS-based ocular therapy allows for inverse planning, providing planners with additional flexibility to shape the radiation field, potentially sparing healthy tissues. PBS enables the use of commercial Monte Carlo algorithms resulting in accurate dose calculations in the presence of heterogeneities and fiducials. The validation consisted of small field dosimetry measurements of point doses, depth doses, and lateral profiles relevant to ocular therapy. A comparison of beam properties achieved through the applicator against published literature is presented. We successfully showed the feasibility of PBS-based ocular treatments. |
format | Online Article Text |
id | pubmed-8931109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89311092022-03-21 Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline Regmi, Rajesh Maes, Dominic Nevitt, Alexander Toltz, Allison Leuro, Erick Chen, Jonathan Halasz, Lia Rengan, Ramesh Bloch, Charles Saini, Jatinder Sci Rep Article Treatment of ocular tumors on dedicated scattering-based proton therapy systems is standard afforded due to sharp lateral and distal penumbras. However, most newer proton therapy centers provide pencil beam scanning treatments. In this paper, we present a pencil beam scanning (PBS)-based ocular treatment solution. The design, commissioning, and validation of an applicator mount for a conventional PBS snout to allow for ocular treatments are given. In contrast to scattering techniques, PBS-based ocular therapy allows for inverse planning, providing planners with additional flexibility to shape the radiation field, potentially sparing healthy tissues. PBS enables the use of commercial Monte Carlo algorithms resulting in accurate dose calculations in the presence of heterogeneities and fiducials. The validation consisted of small field dosimetry measurements of point doses, depth doses, and lateral profiles relevant to ocular therapy. A comparison of beam properties achieved through the applicator against published literature is presented. We successfully showed the feasibility of PBS-based ocular treatments. Nature Publishing Group UK 2022-03-17 /pmc/articles/PMC8931109/ /pubmed/35301371 http://dx.doi.org/10.1038/s41598-022-08440-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Regmi, Rajesh Maes, Dominic Nevitt, Alexander Toltz, Allison Leuro, Erick Chen, Jonathan Halasz, Lia Rengan, Ramesh Bloch, Charles Saini, Jatinder Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title | Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title_full | Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title_fullStr | Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title_full_unstemmed | Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title_short | Treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
title_sort | treatment of ocular tumors through a novel applicator on a conventional proton pencil beam scanning beamline |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931109/ https://www.ncbi.nlm.nih.gov/pubmed/35301371 http://dx.doi.org/10.1038/s41598-022-08440-5 |
work_keys_str_mv | AT regmirajesh treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT maesdominic treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT nevittalexander treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT toltzallison treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT leuroerick treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT chenjonathan treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT halaszlia treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT renganramesh treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT blochcharles treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline AT sainijatinder treatmentofoculartumorsthroughanovelapplicatoronaconventionalprotonpencilbeamscanningbeamline |